Literature DB >> 14760627

Synthesis of curcumin analogues as potential antioxidant, cancer chemopreventive agents.

Khairia M Youssef1, Magda A El-Sherbeny, Faiza S El-Shafie, Hassan A Farag, Omar A Al-Deeb, Sit Albanat A Awadalla.   

Abstract

New series of 3, 5-bis(substituted benzylidene)-4-piperidones, 2, 7-bis(substituted benzylidene)cycloheptanones, 1, 5-bis(substituted phenyl)-1, 4-pentadien-3-ones, 1, 7-bis(substituted phenyl)-1, 6-heptadien-3, 5-diones, 1, 1-bis(substituted cinnamoyl)-cyclopentanes, and 1, 1-bis(substituted cinnamoyl)cyclohexanes have been synthesized and tested for their antioxidant activity. Among the tested compounds, compounds II(4), II(9) II(10), II(11), V(1), and V(4) exhibited higher free radical scavenger activity with % inhibition values of 90.71, 91.24, 96.91, 94.26, 99.23, and 99.85%, respectively. Moreover, compound V(1) is the safest member toward peripheral multinuclear neutrophils (PMNs) with a % viability value of 91%. Detailed synthesis, spectroscopic, and biological data are reported.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14760627     DOI: 10.1002/ardp.200300763

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  22 in total

1.  Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents.

Authors:  Li Lin; Qian Shi; Alexander K Nyarko; Kenneth F Bastow; Chin-Chung Wu; Ching-Yuan Su; Charles C-Y Shih; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2006-06-29       Impact factor: 7.446

2.  Oregonin inhibits lipopolysaccharide-induced iNOS gene transcription and upregulates HO-1 expression in macrophages and microglia.

Authors:  Cheng-Jui Lee; Shoei-Sheng Lee; Su-Chung Chen; Feng-Ming Ho; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

Review 3.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Curcumin analogues exhibit enhanced growth suppressive activity in human pancreatic cancer cells.

Authors:  Lauren Friedman; Li Lin; Sarah Ball; Tanios Bekaii-Saab; James Fuchs; Pui-Kai Li; Chenglong Li; Jiayuh Lin
Journal:  Anticancer Drugs       Date:  2009-07       Impact factor: 2.248

5.  Synthesis and Spectroscopic Studies of Phenanthroimidazole-Imine Derivatives and Evaluation of Their Antioxidant Activity.

Authors:  Sibel Gülle; Seçil Çelik Erbaş; Ataç Uzel
Journal:  J Fluoresc       Date:  2017-10-07       Impact factor: 2.217

6.  The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells.

Authors:  Abdelhabib Semlali; Camille Contant; Basem Al-Otaibi; Ibrahim Al-Jammaz; Fatiha Chandad
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

7.  (3E,5E)-3,5-Bis(4-hy-droxy-3,5-di-methoxy-benzyl-idene)oxan-4-one monohydrate.

Authors:  Zhi-Yun Du; Hua-Rong Huang; Yu-Jun Lu; Kun Zhang; Yan-Xiong Fang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-27

8.  (3E,5E)-3,5-Bis(4-hy-droxy-benzyl-idene)oxan-4-one.

Authors:  Zhi-Yun Du; Hua-Rong Huang; Yu-Jun Lu; Kun Zhang; Yan-Xiong Fang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-11

9.  New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells.

Authors:  Ling Cen; Brian Hutzen; Sarah Ball; Stephanie DeAngelis; Chun-Liang Chen; James R Fuchs; Chenglong Li; Pui-Kai Li; Jiayuh Lin
Journal:  BMC Cancer       Date:  2009-03-30       Impact factor: 4.430

10.  Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategies.

Authors:  Ilaria Postiglione; Angela Chiaviello; Giuseppe Palumbo
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.